Literature DB >> 7764912

Recombinant polymeric IgG: an approach to engineering more potent antibodies.

R I Smith1, S L Morrison.   

Abstract

IgM and IgG are the only classes of immunoglobulin capable of initiating the classical complement cascade. IgM, however, fixes complement much more effectively than IgG making it a more attractive Fc for some immunotherapeutic strategies. IgG, on the other hand, triggers additional effector functions mediated through gamma specific Fc receptors. Using a generalizable technique we have produced IgM-like polymers of IgG that possess both the Fc gamma receptor binding properties of IgG and the more potent complement activity of IgM.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7764912     DOI: 10.1038/nbt0794-683

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  13 in total

1.  Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells.

Authors:  M A Ghetie; E M Podar; A Ilgen; B E Gordon; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  A peptide extension dictates IgM assembly.

Authors:  Dzana Pasalic; Benedikt Weber; Chiara Giannone; Tiziana Anelli; Roger Müller; Claudio Fagioli; Manuel Felkl; Christine John; Maria Francesca Mossuto; Christian F W Becker; Roberto Sitia; Johannes Buchner
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-27       Impact factor: 11.205

3.  Enhanced opsonisation of Rhesus D-positive human red blood cells by recombinant polymeric immunoglobulin G anti-G antibodies.

Authors:  Dylana Díaz-Solano; Jaheli Fuenmayor; Ramon F Montaño
Journal:  Blood Transfus       Date:  2017-05-30       Impact factor: 3.443

4.  Transferrin-antibody fusion proteins are effective in brain targeting.

Authors:  S U Shin; P Friden; M Moran; T Olson; Y S Kang; W M Pardridge; S L Morrison
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

5.  Homogeneous immunoconjugates for boron neutron-capture therapy: design, synthesis, and preliminary characterization.

Authors:  L Guan; L A Wims; R R Kane; M B Smuckler; S L Morrison; M F Hawthorne
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

6.  A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.

Authors:  Gerard Ja Rouwendal; Miranda M van der Lee; Saskia Meyer; Karli R Reiding; Jan Schouten; Guy de Roo; David F Egging; Jeanette Hw Leusen; Peter Boross; Manfred Wuhrer; Gijs F Verheijden; Wim H Dokter; Marco Timmers; Ruud Ubink
Journal:  MAbs       Date:  2015-10-06       Impact factor: 5.857

7.  Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate.

Authors:  Mi-Young Kim; Craig Van Dolleweerd; Alastair Copland; Matthew John Paul; Sven Hofmann; Gina R Webster; Emily Julik; Ivonne Ceballos-Olvera; Jorge Reyes-Del Valle; Moon-Sik Yang; Yong-Suk Jang; Rajko Reljic; Julian K Ma
Journal:  Plant Biotechnol J       Date:  2017-07-15       Impact factor: 9.803

8.  A polymeric immunoglobulin-antigen fusion protein strategy for enhancing vaccine immunogenicity.

Authors:  Gina R Webster; Craig van Dolleweerd; Thais Guerra; Szymon Stelter; Sven Hofmann; Mi-Young Kim; Audrey Y-H Teh; Gil Reynolds Diogo; Alastair Copland; Mathew J Paul; Peter Hart; Rajko Reljic; Julian K-C Ma
Journal:  Plant Biotechnol J       Date:  2018-07-21       Impact factor: 9.803

9.  Multivalent Fcγ-receptor engagement by a hexameric Fc-fusion protein triggers Fcγ-receptor internalisation and modulation of Fcγ-receptor functions.

Authors:  O S Qureshi; T F Rowley; F Junker; S J Peters; S Crilly; J Compson; A Eddleston; H Björkelund; K Greenslade; M Parkinson; N L Davies; R Griffin; T L Pither; K Cain; L Christodoulou; L Staelens; E Ward; J Tibbitts; A Kiessling; B Smith; F R Brennan; M Malmqvist; F Fallah-Arani; D P Humphreys
Journal:  Sci Rep       Date:  2017-12-06       Impact factor: 4.379

10.  Expression of an immunocomplex consisting of Fc fragment fused with a consensus dengue envelope domain III in Saccharomyces cerevisiae.

Authors:  Kum-Kang So; Jeesun Chun; Nguyen Ngoc Luong; Hee-Won Seo; Dae-Hyuk Kim
Journal:  Biotechnol Lett       Date:  2021-07-10       Impact factor: 2.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.